Breaking News

Purdue Pharma Canada Names Corporate Affairs VP

May 16, 2014

Perry responsible for patient access strategies

Grant Perry has been appointed vice president, Government and Corporate Affairs, Purdue Pharma Canada. Mr. Perry will also be responsible for the development and implementation of strategies providing patient access to Purdue's current and future marketed products. Mr. Perry reports to Dr. Craig Landau, president and chief executive officer, and will serve on the executive leadership team.
 
Mr. Perry joins the company from GlaxoSmithKline, where he spent the last 15 years, most recently as vice president, Public Affairs and Reimbursement. He previously held leadership roles within the primary care pharmaceutical and vaccine businesses. Mr. Perry also held roles with Industry Canada and the Pharmaceutical Manufacturers Association of Canada. 
 
Dr. Landau, said, "Grant's impressive work in policy, patient advocacy and market access at both the federal and provincial levels has earned him the reputation of being among the top in his field. His many years of experience and proven record of accomplishment will help Purdue pursue new growth opportunities, while solidifying its position as the leading innovative analgesic pharmaceutical company in Canada.”
 
  • Packaging Equipment Technology Preview

    Packaging Equipment Technology Preview

    February 15, 2017
    Today’s complex drug products present challenges; the latest equipment capabilities help overcome them

  • The Good, the Bad, and the Donald

    The Good, the Bad, and the Donald

    January 31, 2017
    Orphan drugs, CMO continuous manufacturing and developing world sales offer biggest revenue opportunities

  • Predictive Analytics and the Future of RBM

    Rajneesh Patil, Senior Director, RBM and Analytics, QuintilesIMS||January 23, 2017
    How advances in Risk-Based Monitoring will enable a more proactive approach to identify and mitigate potential risks